Kezar Life Sciences Inc’s filing revealed that its Chief Legal Officer Schiller Mark C. unloaded Company’s shares for reported $3879.0 on Jul 02 ’24. In the deal valued at $0.58 per share,6,688 shares were sold. As a result of this transaction, Schiller Mark C. now holds 33,007 shares worth roughly $0.2 million.
Wells Fargo downgraded its Kezar Life Sciences Inc [KZR] rating to an Equal weight from a an Overweight in a research note published recently. A number of analysts have revised their coverage, including William Blair’s analysts, who decreased its forecast for the stock in mid March from “an Outperform” to “a Mkt perform”. Wells Fargo began covering KZR with “an Overweight” recommendation on December 08, 2021. William Blair started covering the stock on July 16, 2018. It rated KZR as “an Outperform”.
Price Performance Review of KZR
On Friday, Kezar Life Sciences Inc [NASDAQ:KZR] saw its stock fall -2.37% to $6.19. Over the last five days, the stock has lost -4.92%. Kezar Life Sciences Inc shares have fallen nearly -7.89% since the year began. Nevertheless, the stocks have fallen -29.66% over the past one year. While a 52-week high of $11.35 was reached on 01/03/25, a 52-week low of $5.20 was recorded on 01/15/25. SMA at 50 days reached $6.95, while 200 days put it at $6.98.
Levels Of Support And Resistance For KZR Stock
The 24-hour chart illustrates a support level at 6.02, which if violated will result in even more drops to 5.86. On the upside, there is a resistance level at 6.49. A further resistance level may holdings at 6.80. The Relative Strength Index (RSI) on the 14-day chart is 38.31, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.26, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 94.88%. Stochastics %K at 16.33% indicates the stock is a buying.
How much short interest is there in Kezar Life Sciences Inc?
A steep rise in short interest was recorded in Kezar Life Sciences Inc stocks on 2024-10-31, growing by 79671.0 shares to a total of 0.18 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 98290.0 shares. There was a rise of 44.77%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on July 16, 2018 when Wells Fargo began covering the stock and recommended ‘”an Outperform”‘ rating along with a $30 price target.
